INOVIO Announces Proposed Public Offering of its Common Stock

PLYMOUTH MEETING, Pa., Nov. 5, 2026 // -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it intend…